Quality of water in pharmaceutical industry

Water is a key element for numerous pharmaceutical and life sciences processes. As a raw material, water is used in processing, formulation and manufacturing various pharmaceutical products and active pharmaceutical ingredients (API). Most industries rely majorly on surface water and groundwater sources for their pharmaceutical purposes. In its natural state, water from these sources is not free from contamination and needs to be purified before industries use it for pharmaceutical purposes.
This process of water purification involves distillation and deionization that reduces the concentration of contaminated particles, parasites, bacteria, algae, viruses, and fungi. It is imperative that water is treated using proper procedures to ensure its purity.
Depending on the route of administration of the pharmaceutical product, different pharmaceutical water systems quality are required. Based on water quality, below are different types of water used for pharmaceutical purposes.

Drinking Water

Drinking water can be best described as Potable water. It may be sourced from a public water utility, a private water supply (e.g., a well) or a combination of both. Drinking water is the minimum quality of water that ought to be used for the preparation of official substances and other bulk pharmaceutical substances. The treatment required to make it safe for human consumption is determined post evaluating the condition of the source water. Drinking water, free from contamination is used for cleaning pharmaceutical manufacturing equipment and product-contact components. Some common methods of treatment include desalinization, softening, deionization, particle reduction, and reduction of inorganic and/or organic materials.
The equipment and systems used to produce drinking water, their storage tanks, distribution pipeworks and the water quality itself need to be routinely monitored for environmental, seasonal or supply changes which may affect the integrity of the water systems in place. Additionally, techniques such as backflushing, chemical and /or thermal sanitization should be put in place to tackle the recontamination of water.

Purified Water

Purified water is used mainly as an excipient in the production of non-parenteral administrations and in other pharmaceutical applications. Non-parenteral is most commonly referred to as the route that oral medications are administered, therefore it is of utmost importance that water used for non-parenteral preparations must meet the requirements for ionic and organic chemical purity.
Purified water is generally produced by ion exchange, reverse osmosis, and ultrafiltration. While producing purified water it is important to protect it from recontamination and other microbial protection.

Highly Purified Water (HPW)

Highly Purified Water or HPW is a unique specification for water found only in the European Pharmacopoeia
The European Pharmacopoeia has a unique specification for water called highly purified water (HPW). For preparing, HPW drinking water should be used as a minimum quality water source. HPW must satisfy the same quality standard as Water for Injections (WFI) however, the water treatment process may be different.
HPW can be processed by a mixture of different practices such as RO, ultrafiltration and deionization. Needless to say, highly purified water should be protected from recontamination and microbial proliferation.

Water for Injections (WFI)

Water for Injections or WFI is majorly used as an excipient in manufacturing parenteral and other pharmaceutical preparations where endotoxin must be controlled. WFI should be prepared with drinking water or purified water as a minimum quality feed water.
Chemical purity in WFI poses a major problem for pharmaceutical manufacturers. The microbiological quality of the water needs to be consistent in testing and should comply with the requirements for bacterial endotoxins being not more than 0.25 IU of endotoxin per ml. The only dependable process of producing reliable WFI is multi-effect distillation. It remains unchallenged as the only official method for producing WFI.
WFI in itself is not sterile and is an intermediate bulk product that is best suited to be used as an ingredient during the formulation of other pharmaceutical products. Hence, WFI should also be protected from recontamination and microbial proliferation.

As stated above, maintaining water quality is a crucial practice for all companies involved in manufacturing or processing pharmaceutical substances. Right from determining the quality of the water source to choosing a suitable treatment method to purify it, water systems need to be designed and operated under proper regulatory guidelines. Therefore it is vital that you make the right decision and choose a certified water treatment plant manufacturer that has a proven track record of helping its partners. Associating with the right water treatment plant manufacturers can help your business achieve all your purity optimization needs; eliminating physical, chemical and microbiological impurities.

Share this post:

For 20 years, we’ve been the go-to problem-solvers for high-purity and injectable process applications in the pharma and biopharma industry. We are relentless about continuous process improvement and upskilling, elevating ourselves and our technology so you can get the job done more efficiently with cost optimisations. Use the form below to schedule a call back from our team.

Name(Required)
This field is for validation purposes and should be left unchanged.

Hetal Panchal is the Vice President in Operations department of TSA Process Equipments (A Thermax Group Company) since 1 s t October 2012.

Holding a qualification in Production Engineering and 28 years of industry experience, he specializes in designing advanced equipment for the pharmaceutical sector. His expertise lies in optimizing production lines, improving efficiency, and ensuring compliance with regulatory standards.
Focused on innovation, he has developed systems that enhances productivity, minimizes downtime, and maintains product quality. Staying current with technological trends, they contribute to ongoing improvements in the industry.
His extensive experience has helped identify opportunities for innovation, streamlining operations and reducing costs. Through his specialized knowledge, more efficient manufacturing processes and higher-quality outputs in pharmaceutical production are delivered.

B.C. Mahesh is the Chairperson of TSA Process Equipment Pvt. Ltd. since Feb 2024.

B.C. Mahesh became a member of the Executive Council in August 2013. He is responsible for the Industrial Product Business (IPB), which consists of Process Heating, Absorption Cooling & Heating Solutions, Water and Waste Solutions, Air Pollution Control, Steam Engineering, Channel Business Group, International Business Group, and Enterprise Sales businesses.
As part of IPB, he also oversees the following wholly-owned subsidiaries
of Thermax – Danstoker, PT Thermax International Indonesia and Rifox.Mahesh joined Thermax as a graduate trainee in 1988 and handled the Materials function for various businesses, including global sourcing, till 1996.
He moved to the Power division(P&ES) and grew to the position of Sales Head and subsequently Head of Projects. He took over as the Head of the SBU for Medium Power Plants in 2009 and finally as Head of Power business in 2012.
Mahesh has worked with Thermax for over 30 years in many functions such as manufacturing, supply chain, sales and marketing, and project management, and has played a significant role in the strategy, expansion and diversification of the Power business.Mahesh completed his Mechanical Engineering from the Visvesvaraya Regional College of Engineering, Nagpur in 1988.

Vishal Mehra is the Director of TSA Process Equipment Pvt. Ltd. since Feb 2024.

Mr. Vishal Mehra is currently serving as the Strategic Business Unit Head for Water & Waste Solutions (WWS) at Thermax Limited. Additionally, he holds a directorial position at TSA Process Equipment, which is known for its expertise in ultra-pure and high-purity water technologies and was recently acquired by Thermax.With over 22 years of experience in the industry, Mr. Mehra’s professional focus includes water management solutions, advanced technology development, and business strategy.
His areas of interest encompass cutting-edge technology, growth strategies, organizational effectiveness, and development.
Mr. Mehra is well qualified in business management and strategy transformation, having completed the Senior Executive Program in Business Management and Strategy Transformation from London Business School. This advanced education supports his extensive experience and expertise in the field.

Sandeep Deshpande has been the Director of TSA Process Equipments Pvt. Ltd. since February 2024.

Currently, he serves as the Head of Corporate Finance and the Industrial Product Group at Thermax Limited. With over 21 years of experience in finance, he has developed expertise in financial consolidation, planning, reporting, costing, accounting, controlling and financial modeling.
Currently, he serves as the Head of Corporate Finance and the Industrial Product Group at Thermax Limited. With over 21 years of experience in finance, he has developed expertise in financial consolidation, planning, reporting, costing, accounting, controlling and financial modeling.
Sandeep is a qualified Cost Accountant Company Secretary, and holds a diploma in IFRS and an advanced diploma in financial management from XLRI. He has extensive experience in financial operations, including financial planning, MIS, budgeting, controlling, audits, and cash flow management. His expertise also spans financial reporting, consolidation, mergers and acquisitions, due diligence, business restructuring, and implementing Internal Financial Control (IFC) and Enterprise Risk Management (ERM). Additionally, Sandeep has hands-on experience with Oracle systems, automation, digitization, and business analytics. He is passionate about driving good governance, improving financial reporting, and leveraging automation and digitization to enhance business analytics.

Rajiv Parikh is the COO of TSA Process Equipments (A Thermax Group Company) since April 2024.

Rajiv is a highly accomplished professional with extensive experience in the pharmaceutical and FMCG sectors, specializing in high-purity and process vessels. He played a key role in establishing TSA Process Equipments Pvt. Ltd., driving its growth and success. His deep technical expertise, combined with a strong understanding of client needs, has enabled him to deliver innovative solutions to complex industry challenges.

Throughout his career, Rajiv has excelled in leadership and sales, consistently launching cutting-edge products that have positively impacted the market. His ability to build lasting client relationships and offer tailored solutions has earned him a reputation as a trusted industry leader.

With a background in Mechanical Engineering, Rajiv blends technical proficiency with strategic vision. His contributions have shaped industry standards and positioned him as a key influencer in the pharmaceutical and FMCG sectors.

Apurva Shah is the CEO of TSA Process Equipments (A Thermax Group Company) since April 2024.

With a career spanning over 24 years, Apurva is the visionary CEO of TSA Process Equipments, where he has led the company to new heights in the High Purity & process equipment industry. A graduate in Mechanical Engineering from Mumbai University, followed by an MBA in Business Management from NMIMS, He brings a strong technical foundation combined with a sharp strategic mindset.

His expertise lies in formulating and executing strategies that drive growth and operational efficiency. Over the years, he has cultivated a deep understanding of market dynamics, positioning TSA Process Equipments for continued success in a competitive landscape.

Outside of his professional pursuits. He is an avid reader, with a particular interest in fiction novels, which fuel his creativity and broaden his perspective.